Skip to Content

Rolatuss-SR (atropine / chlorpheniramine / hyoscyamine / phenylephrine / phenylpropanolamine / scopolamine) Drug Interactions

A total of 1021 drugs (6393 brand and generic names) are known to interact with Rolatuss-SR (atropine / chlorpheniramine / hyoscyamine / phenylephrine / phenylpropanolamine / scopolamine).

  • 257 major drug interactions (1987 brand and generic names)
  • 707 moderate drug interactions (3876 brand and generic names)
  • 57 minor drug interactions (530 brand and generic names)

Check for interactions with Rolatuss-SR (atropine / chlorpheniramine / hyoscyamine / phenylephrine / phenylpropanolamine / scopolamine)

Type in a drug name and select a drug from the list.

Medications known to interact with Rolatuss-SR (atropine / chlorpheniramine / hyoscyamine / phenylephrine / phenylpropanolamine / scopolamine)

Show me: Generic only

Jump to: 1 4 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

    1
    4
    9
    A
    B
    C
    D
    E
    F
    G
    H
    I
    J
    K
    L
    M
    N
    O
    P
    Q
    R
    S
    T
    U
    V
    W
    X
    Y
    Z

    Rolatuss-SR (atropine / chlorpheniramine / hyoscyamine / phenylephrine / phenylpropanolamine / scopolamine) alcohol/food Interactions

    There are 6 alcohol/food interactions with Rolatuss-SR (atropine / chlorpheniramine / hyoscyamine / phenylephrine / phenylpropanolamine / scopolamine)

    Rolatuss-SR (atropine / chlorpheniramine / hyoscyamine / phenylephrine / phenylpropanolamine / scopolamine) disease Interactions

    There are 28 disease interactions with Rolatuss-SR (atropine / chlorpheniramine / hyoscyamine / phenylephrine / phenylpropanolamine / scopolamine) which include:

    Drug Interaction Classification

    The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.

    Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
    Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
    Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.

    Do not stop taking any medications without consulting your healthcare provider.